Hong Kong, China -- June 24, 2019 – Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, has entered into a strategic...

The National Cancer Center of Japan (“NCC”) today announced the signing of a collaboration between its Cancer Genomic Screening Project...